The analysis of CTC in CRPC patients

The analysis of CTC in CRPC patients - The analysis of CTC in CRPC patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019267

Enrollment

100

Registered

2015-12-21

Start date

2015-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CRPC

Interventions

doxetaxel cabazitaxel abiraterone enzalutamide

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: CRPC confirmed

Exclusion criteria

Exclusion criteria: Uncontroled general complication. etc

Design outcomes

Primary

Measure	Time frame
CTC count etc	—

Countries

Japan

Contacts

Public ContactTakeo Kosaka

Keio University School of Medicine Department of Urology

takemduro@a6.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026